Delivery Order SPE2DB20D2104-SPE2DB22FR95T
- Not listed
- The federal contract award is for the delivery of epinephrine 1 mg/ml ampules to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm-fixed-price delivery order with a ceiling value of $2,404.90 and an ultimate completion date of May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set-aside and was competitively awarded....
- This federal contract award is for the delivery of Epinephrine 1 mg/mL ampoules to the Defense Logistics Agency (DLA). The contract, valued at $1,287.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award from the Defense Logistics Agency (DLA) is for the supply of epinephrine 1 mg/mL ampoules to the U.S. government. The contract has a ceiling value of $1,607.11 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This federal contract award is for the delivery of Epinephrine 1 mg/mL Ampul/mL, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,120.78 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that plays a significant role in supplying medical products to federal government agencies. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The $4,135.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 1, 2025 with a completion date of May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 1 mg/mL ampules. The $1,122.00 firm-fixed-price delivery order has a completion date of December 12, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award is a delivery order valued at $1,190.67 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of epinephrine 1 mg/mL ampuls, a critical medication used for the treatment of severe allergic reactions. The contract is a firm fixed-price, non-set-aside arrangement with a performance period extending through April 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The $3,087.98 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025, with a completion date of July 18, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Epinephrine 1 mg/ml ampules. The contract is a Delivery Order valued at $1,362.20 with a firm fixed price and a completion date of July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,075.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR95TDelivery Order
This federal contract award is for the delivery of epinephrine 1 mg/mL ampoules, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,307.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 1, 2022, with a completion date of March 2, 2022. The contract is not set-aside and was awarded under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The DLA Troop Support Medical is the primary contracting agency, leveraging Amerisourcebergen's extensive supply chain and distribution capabilities to efficiently fulfill the government's critical pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/1/22 |